About
Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 4 investors are based in Tonghua, Shanxi, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Tonghua, China
Contact Information
linkedin.com/in/••••••••
Find more investors like Tonghua
Search Investors